BuybackJun 29, 2026, 10:36 AM
GSK Completes £2 Billion Share Buyback Program
AI Summary
GSK plc announced the successful completion of its £2 billion share buyback program, which was initially announced on February 24, 2025. Since the program's inception, the company has repurchased 123,939,156 ordinary shares for an aggregate consideration of just under £2 billion. The filing details recent purchases made between June 22 and June 26, 2026, totaling 1,054,653 ordinary shares, which will be held as treasury shares. Following these transactions, GSK holds 270,881,064 ordinary shares in treasury, representing 6.70% of the total voting rights.
Key Highlights
- GSK completed its £2 billion share buyback program announced on February 24, 2025.
- The company purchased 123,939,156 ordinary shares for just under £2 billion since February 24, 2025.
- From June 22-26, 2026, GSK purchased 1,054,653 ordinary shares through Citigroup Global Markets Limited.
- The volume weighted average price for these purchases ranged from 1,919.89 GBp to 1,967.46 GBp.
- Following these purchases, GSK holds 270,881,064 ordinary shares as treasury shares.
- The total number of ordinary shares in issue (excluding treasury shares) is 4,045,395,364.
- Treasury shares now represent 6.70% of the company's voting rights.
Price Impact
More from GSK